Tourmaline Bio, Inc. - Common Stock (TRML)
15.98
-0.55 (-3.33%)
Tourmaline Bio, Inc. is a biotechnology company focused on the development of innovative therapies harnessing the power of the immune system to treat various diseases, particularly challenging conditions such as cancer and autoimmune disorders
The company leverages advanced technology platforms to engineer and optimize biologic products, aiming to enhance the potential of immune modulation and provide breakthrough treatment options for patients. Through rigorous research and clinical development, Tourmaline Bio is committed to advancing its pipeline of novel therapeutics to transform patient care and improve health outcomes.
Frequently Asked Questions
Is Tourmaline Bio, Inc. - Common Stock publicly traded?
Yes, Tourmaline Bio, Inc. - Common Stock is publicly traded.
What exchange does Tourmaline Bio, Inc. - Common Stock trade on?
Tourmaline Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tourmaline Bio, Inc. - Common Stock?
The ticker symbol for Tourmaline Bio, Inc. - Common Stock is TRML on the Nasdaq Stock Market
What is the current price of Tourmaline Bio, Inc. - Common Stock?
The current price of Tourmaline Bio, Inc. - Common Stock is 15.98
When was Tourmaline Bio, Inc. - Common Stock last traded?
The last trade of Tourmaline Bio, Inc. - Common Stock was at 4:00 pm EST on February 5th, 2025